Skip to main content Skip to section navigation Skip to footer

Mydecine Innovations Group Inc.

  • Home
  • About
    • Overview
    • Company History
    • Acquisitions
    • Partnerships
    • Leadership Team
    • Board of Directors
    • Research & Development Team
    • Medical, Scientific and Technology Advisory Board
  • Our Approach
    • IP & Drug Development
    • Clinical Trials
    • Technology
  • Drug Supply
    • Investigational Drug Supply
    • Special Access Program
  • News & Media
    • Blog
    • Press Releases
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEDAR
    • Governance
    • FAQs
  • Contact
  • Careers
  • Search

Press Releases

News & Media

News & Media

  • Blog
  • Press Releases
  • In The News
May 02, 2022 3:57pm EDT

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Apr 27, 2022 9:31pm EDT

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT

Apr 13, 2022 5:05pm EDT

Mydecine Announces Reverse Stock-Split

Mar 31, 2022 10:03pm EDT

Mydecine Reports Financial Results for the Fiscal Year 2021 and Provides a Business Update

Mar 31, 2022 3:45pm EDT

Mydecine Innovations Group Announces Closing of First Tranche Under Share Subscription Agreement

Mar 24, 2022 7:30am EDT

Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study

Mar 03, 2022 7:30am EST

Mydecine To Attend March Investor Conferences

Mar 01, 2022 7:30am EST

Mydecine Reports Positive Pre-IND Meeting With FDA For MYCO-001 Smoking Cessation Study

Feb 16, 2022 7:30am EST

Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules

Feb 08, 2022 7:30am EST

Mydecine’s Exclusive Dealer Identified as Licensed Psilocybin and MDMA Supplier in Canada

rss_feed News RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward

Sign up for our Newsletter!

twitter Linkedin Instagram
©2022 Mydecine Innovations Group Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap